Dan Shores Quoted in Bloomberg Law Article on the Moderna/Pfizer Covid-19 Patent Infringement Lawsuit and the Future of Vaccine IP Disputes

Partner Dan Shores is quoted in a Bloomberg Law article titled "Moderna Patent Strike on Pfizer Sets Up Post-Covid Vaccine Feuds" dated Monday, August 29, 2022.

Moderna's recent lawsuit, alleging Pfizer infringed three of its patents related to messenger RNA (mRNA) in its Covid-19 vaccine, may have an affect on future mRNA technology. If Moderna is successful in its lawsuit, it will be in a position to license its technology to other pharmaceutical companies working on future vaccines. But this isn't the first patent infringement lawsuit involving mRNA, and it certainly won't be the last.

"'Moderna, BioNTech, and Curevac—each one of those entities has a tremendous patent estate,' [Dan] said. What’s more, 'each one of those companies was founded and grew based on messenger RNA technology.'

And the 'scope of possibilities' with mRNA technologies, [Dan] said, is vast, touching on other infectious diseases and oncology.

'It’s quite possible we will see additional lawsuits for different advancements in the mRNA space moving forward...It’s a dawn of a new era in therapeutics.'"

To view the article in its entirety, visit the Bloomberg Law website.